サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1795194

ワクチン・バイアル・モニターの世界市場

Vaccine Vial Monitors

出版日
ページ情報
英文 273 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.28円
ワクチン・バイアル・モニターの世界市場
出版日: 2025年08月21日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 273 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ワクチン・バイアル・モニターの世界市場は2030年までに3億4,010万米ドルに達する見込み

2024年に2億3,300万米ドルと推定されるワクチン・バイアル・モニターの世界市場は、2030年には3億4,010万米ドルに達し、分析期間2024-2030年のCAGRは6.5%で成長すると予測されます。本レポートで分析したセグメントの1つであるマルチドーズモニターは、CAGR 5.0%を記録し、分析期間終了時には1億8,810万米ドルに達すると予測されます。単回投与モニターセグメントの成長率は、分析期間中CAGR 8.6%と推定されます。

米国市場は6,350万米ドルと推定、中国はCAGR 10.0％で成長予測

米国のワクチン・バイアル・モニター市場は、2024年に6,350万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 10.0％で推移し、2030年には6,920万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と6.2％と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界のワクチン・バイアル・モニター市場- 主要動向と促進要因のまとめ

なぜワクチン・バイアル・モニターは世界のワクチンの安全性と有効性を確保する上で重要なのか？

ワクチン・バイアル・モニター（VVM）は、製造から投与までワクチンの有効性を維持することで、世界の予防接種プログラムに不可欠な役割を果たしています。色が変化するこの小さなインジケータは、ワクチンバイアルに貼付され、時間の経過とともに累積する熱曝露を視覚的に示すことで、医療従事者がワクチンが危険にさらされているかどうかを判断するのに役立ちます。世界の多くの地域、特に遠隔地や資源の限られた地域では、切れ目のないコールドチェーンを維持することが大きな課題となっています。温度変動はワクチンを劣化させ、効果を低下させたり、完全に不活性化させたりする可能性がありますが、劣化の兆候は必ずしも目に見えるものではありません。VVMは、高度な技術を必要とせず、現場の医療従事者が十分な情報に基づいた意思決定を行えるようにする、シンプルで費用対効果の高いツールとして機能します。効果のないワクチンの投与を防ぐことで、公衆衛生を守り、予防接種プログラムに対する信頼を強化することができます。WHOやユニセフといった国際保健機関は、特に麻疹、ポリオ、結核といった疾病を対象とした予防接種プログラムにおいて、VVMを標準要件としています。特にパンデミックやアウトブレイクに対応してワクチン接種の規模を拡大する国が増えるにつれて、ワクチンの完全性を維持することの重要性はさらに顕著になっています。VVMは、ワクチン流通の全段階にわたって透明性、説明責任、安全性を提供し、保管の連鎖における不可欠なチェックポイントとしての役割を果たしています。

ワクチン・バイアル・モニターの機能はどのように向上していますか？

ワクチン・バイアル・モニターの機能性と信頼性は、材料科学、熱化学、インジケータ設計の進歩により大幅に改善されました。従来のVVMは、累積熱暴露に反応して色が変化する時間温度感受性色素に依存していましたが、新世代のモニターは、より正確で、解釈しやすく、幅広い温度プロファイルに対応するように設計されています。これらの改良により、mRNAベースの製剤のような超低温保存を必要とするものを含め、様々なタイプのワクチンに適したVVMの開発が可能になりました。接着剤やインクの配合が改良されたことで、過酷な条件下でもインジケーターがしっかりと固定され、視認性が保たれるようになりました。メーカー各社はまた、医療従事者がバイアルの温度履歴、有効期限切れ状態、バッチの出所に関するデータをスキャンして記録できるQRコードなど、VVMにデジタル機能を統合することにも取り組んでいます。一部の次世代VVMは、近距離無線通信（NFC）チップやBluetooth機能を搭載して開発されており、スマートフォンや接続されたデバイスを介したリアルタイムのモニタリングを可能にしています。これらの技術は、データ収集の改善、無駄の削減、物流の混乱への迅速な対応を目指すワクチン販売業者や保健省にとって特に価値があります。さらに、VVMのデザインは、より明確な視覚的インジケータ、改ざん防止機能、多様なヘルスケア環境をサポートする多言語説明書など、よりユーザー中心になってきています。こうした技術的進歩により、コールドチェーンにおけるインテリジェントなツールとしてのVVMの役割が強化され、ワクチンの品質保証が強化され、人為的ミスや保管の失敗に伴うリスクが軽減されています。

ワクチン・バイアル・モニターの需要を牽引する世界・ヘルス・イニシアチブと市場とは？

世界の予防接種活動の規模が拡大し、複雑化していることが、ワクチン・バイアル・モニターに対する大きな需要の原動力となっています。特に、インフラの制約がコールドチェーン不全のリスクを高めている地域では、その傾向が顕著です。特にGavi、WHO、UNICEFなどの組織が主導する大規模な予防接種イニシアチブでは、アフリカ、南アジア、ラテンアメリカの一部で配布されるワクチンの調達基準にVVMを組み込んでいます。これらの地域では、電力供給の変動、冷蔵能力の制限、長い輸送ルートなどに直面することが多く、VVMは厳しい条件下でワクチンの有効性を守るために不可欠です。ロタウイルス、HPV、黄熱病などの国家予防接種プログラムを実施している国々では、VVVは第一線の医療従事者がワクチンの安全な評価と投与を行うための信頼性を提供します。COVID-19ワクチンの展開により、信頼性の高いモニタリングの必要性がさらに強調され、多くのmRNAワクチンは当初超低温保存が必要であったが、ロジスティクスの適応と新しい製剤により、現在ではより広範な公衆衛生での使用が可能となり、専門的なVVMへの需要が高まっています。中所得国もまた、コールドチェーン近代化の取り組みの一環としてこれらの指標を採用しており、多くの場合、二国間の保健パートナーシップや海外からの援助によって支えられています。さらに、製薬企業や製造委託機関は、国際基準を満たし、製品のトレーサビリティを確保するために、VVMを製造・流通プロトコルに組み込んでいます。政府プログラムだけでなく、人道援助団体や災害対応機関も、緊急環境において安全な予防接種を提供するためにVVMを利用しています。こうした広範かつ多様な使用事例により、世界のVVM市場は持続的な需要と技術革新を確保しています。

ワクチン・バイアル・モニター市場の成長を促進する主な要因とは？

ワクチン・バイアル・モニター市場の成長は、予防接種プログラムの拡大、世界ヘルスへの投資の増加、規制要件の増加、コールドチェーンの脆弱性に対する意識の高まりなど、いくつかの重要な要因によって牽引されています。ユニバーサル・ワクチン・カバレッジの達成とワクチンで予防可能な病気の撲滅に取り組む国が増えるにつれ、VVMのような信頼性の高い品質保証ツールの必要性は高まり続けています。GaviのCOVAXプログラムや世界銀行のパンデミック対策などのイニシアティブによる世界の資金援助も、低・中所得国におけるVVMの広範な調達と実施を可能にしています。WHOや各国の保健省を含む規制機関は、特に公共部門を通じて流通する全ての熱感受性ワクチンにVVMの使用を義務付けています。このような政策により、メーカー各社は自社のワクチンライン全体でVVMの統合を標準化するよう促されています。さらに、低温または超低温保存を必要とするワクチンの需要の急増は、包括的なコールドチェーン検証の一環としての温度感受性指標の重要性を浮き彫りにしています。また、VVMの設計と使い勝手の技術的な向上も成長を後押ししています。新型モデルは性能とデータ追跡機能が強化されており、国際保健機関と商業バイヤーの双方にアピールしています。さらに、ワクチン廃棄物の削減とサプライチェーンの最適化にますます注目が集まっていることから、VVMは持続可能性の目標にも貢献するコスト削減ツールとして位置づけられています。これらの要因が相まって、ワクチン・バイアル・モニターの戦略的価値が強化され、ワクチンの安全性、ロジスティクス、公衆衛生保証において不可欠な資産として継続的な成長を確実なものにしています。

セグメント

タイプ（マルチドーズモニター、シングルドーズモニター）;アプリケーション（予防ワクチンアプリケーション、治療ワクチンアプリケーション）

調査対象企業の例

  • 3M Company
  • Avantor（VWR）
  • Berlinger & Co. AG
  • Cardinal Health
  • Catalent, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Elitech Technology, Inc.
  • ELPRO-BUCHS AG
  • Gerresheimer AG
  • Lisaline Lifescience Technologies Pvt Ltd
  • LogTag Recorders（North America Inc.）
  • Nipro Corporation
  • Pacific Vial Manufacturing
  • Parsyl, Inc.
  • Schott AG
  • Sensitech, Inc.
  • Stevanato Group
  • Temptime Corporation（Zebra Technologies）
  • Thermo Fisher Scientific Inc.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP38300

Global Vaccine Vial Monitors Market to Reach US$340.1 Million by 2030

The global market for Vaccine Vial Monitors estimated at US$233.0 Million in the year 2024, is expected to reach US$340.1 Million by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Multi-Dose Monitors, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$188.1 Million by the end of the analysis period. Growth in the Single Dose Monitors segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$63.5 Million While China is Forecast to Grow at 10.0% CAGR

The Vaccine Vial Monitors market in the U.S. is estimated at US$63.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$69.2 Million by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Vaccine Vial Monitors Market - Key Trends & Drivers Summarized

Why Are Vaccine Vial Monitors Critical in Ensuring Vaccine Safety and Efficacy Worldwide?

Vaccine Vial Monitors (VVMs) play an indispensable role in global immunization programs by ensuring that vaccines remain effective from production to administration. These small, color-changing indicators are affixed to vaccine vials and provide a visual cue about cumulative heat exposure over time, helping health workers determine whether a vaccine has been compromised. In many parts of the world, particularly in remote or resource-limited areas, maintaining an unbroken cold chain is a significant challenge. Temperature excursions can degrade vaccines, rendering them less effective or even completely inactive, and yet the signs of degradation are not always visible. VVMs act as simple, cost-effective tools that empower frontline health workers to make informed decisions without requiring sophisticated technology. They help prevent the administration of ineffective vaccines, thus safeguarding public health and reinforcing trust in immunization programs. International health organizations such as WHO and UNICEF have made VVMs a standard requirement for vaccines supplied through their programs, especially those targeting diseases like measles, polio, and tuberculosis. As more countries scale up vaccination efforts, particularly in response to pandemics or outbreaks, the importance of maintaining vaccine integrity has become even more pronounced. VVMs serve as an essential checkpoint in the chain of custody, offering transparency, accountability, and safety across all stages of vaccine distribution.

How Are Technological Improvements Enhancing the Capabilities of Vaccine Vial Monitors?

The functionality and reliability of Vaccine Vial Monitors have been significantly improved through advances in materials science, thermal chemistry, and indicator design. Traditional VVMs rely on a time-temperature sensitive dye that changes color in response to cumulative heat exposure, but newer generations of monitors are more precise, easier to interpret, and designed for a broader range of temperature profiles. These improvements have enabled the development of VVMs suited for various types of vaccines, including those requiring ultracold storage such as mRNA-based formulations. Enhanced adhesives and ink formulations now ensure that indicators remain firmly attached and legible even under harsh conditions. Manufacturers are also working on integrating digital features with VVMs, such as QR codes that allow health workers to scan and log data related to a vial’s temperature history, expiration status, and batch origin. Some next-generation VVMs are being developed with near-field communication (NFC) chips or Bluetooth capabilities, enabling real-time monitoring via smartphones or connected devices. These technologies are particularly valuable for vaccine distributors and health ministries aiming to improve data collection, reduce waste, and respond quickly to logistical disruptions. Furthermore, VVM design is becoming more user-centric, with clearer visual indicators, tamper-evidence features, and multilingual instructions to support diverse healthcare settings. These technological advancements are reinforcing the role of VVMs as intelligent tools in the cold chain, enhancing vaccine quality assurance and reducing the risks associated with human error or storage failure.

Which Global Health Initiatives and Markets Are Driving Demand for Vaccine Vial Monitors?

The increasing scale and complexity of global vaccination efforts are driving significant demand for Vaccine Vial Monitors, especially in regions where infrastructure limitations elevate the risk of cold chain failure. Large-scale immunization initiatives, particularly those spearheaded by organizations such as Gavi, WHO, and UNICEF, have integrated VVMs into the procurement criteria for vaccines distributed in Africa, South Asia, and parts of Latin America. These regions often face fluctuating power supplies, limited refrigeration capacity, and long transportation routes, making VVMs essential for protecting vaccine efficacy under challenging conditions. In countries implementing national immunization programs for diseases like rotavirus, HPV, and yellow fever, VVMs provide frontline health workers with the confidence to assess and administer vaccines safely. The rollout of COVID-19 vaccines further emphasized the need for reliable monitoring, and while many mRNA vaccines required ultracold storage initially, logistical adaptations and new formulations are now bringing them into broader public health use, reinforcing demand for specialized VVMs. Middle-income nations are also adopting these indicators as part of broader cold chain modernization efforts, often supported by bilateral health partnerships and foreign aid. Additionally, pharmaceutical companies and contract manufacturing organizations are embedding VVMs in their production and distribution protocols to meet international standards and ensure product traceability. Beyond government programs, humanitarian aid groups and disaster response agencies also rely on VVMs to deliver safe immunizations in emergency settings. These widespread and varied use cases are ensuring sustained demand and innovation in the global VVM market.

What Key Factors Are Driving Growth in the Vaccine Vial Monitors Market?

The growth in the vaccine vial monitors market is driven by several critical factors, including expanding immunization programs, rising global health investment, increased regulatory requirements, and heightened awareness about cold chain vulnerabilities. As more countries commit to achieving universal vaccine coverage and eradicating vaccine-preventable diseases, the need for reliable quality assurance tools like VVMs continues to increase. Global funding from initiatives such as Gavi’s COVAX program and the World Bank’s pandemic preparedness efforts is also enabling broader procurement and implementation of VVMs in low- and middle-income countries. Regulatory bodies, including WHO and national ministries of health, are mandating the use of VVMs on all heat-sensitive vaccines, especially those distributed through public-sector channels. These policies are encouraging manufacturers to standardize VVM integration across their vaccine lines. Additionally, the surge in demand for vaccines requiring cold or ultracold storage is spotlighting the importance of temperature-sensitive indicators as part of comprehensive cold chain validation. Technological improvements in VVM design and usability are also fueling growth, as newer models offer enhanced performance and data tracking capabilities that appeal to both global health organizations and commercial buyers. Moreover, the increasing focus on vaccine waste reduction and supply chain optimization is positioning VVMs as cost-saving tools that also contribute to sustainability goals. Together, these factors are reinforcing the strategic value of vaccine vial monitors and ensuring their continued growth as indispensable assets in vaccine safety, logistics, and public health assurance.

SCOPE OF STUDY:

The report analyzes the Vaccine Vial Monitors market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Multi-Dose Monitors, Single Dose Monitors); Application (Preventive Vaccine Application, Therapeutic Vaccine Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 3M Company
  • Avantor (VWR)
  • Berlinger & Co. AG
  • Cardinal Health
  • Catalent, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Elitech Technology, Inc.
  • ELPRO-BUCHS AG
  • Gerresheimer AG
  • Lisaline Lifescience Technologies Pvt Ltd
  • LogTag Recorders (North America Inc.)
  • Nipro Corporation
  • Pacific Vial Manufacturing
  • Parsyl, Inc.
  • Schott AG
  • Sensitech, Inc.
  • Stevanato Group
  • Temptime Corporation (Zebra Technologies)
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Vaccine Vial Monitors - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Global Immunization Programs Throw the Spotlight on Heat-Sensitive Labeling and Monitoring Solutions
    • Rising Demand for Cold Chain Assurance Spurs Widespread Use of Vaccine Vial Monitors in Low-Resource Settings
    • Here's How WHO Prequalification and Gavi Procurement Are Driving Standardization and Global Adoption of VVMs
    • Expansion of Temperature-Sensitive Vaccine Portfolios Strengthens the Business Case for Advanced Vial-Level Monitoring
    • Growing Need for Visual, Low-Cost Quality Indicators in Remote Areas Propels Demand for Color-Change VVMs
    • Here's the Story: How mRNA and ULT Vaccine Rollouts Are Creating Demand for High-Sensitivity Monitoring Labels
    • Digitization of Vaccine Supply Chains Drives Interest in Smart VVMs with Integrated Data Logging or QR Code Traceability
    • Public Health Campaigns and Mobile Vaccination Units Expand the Addressable Market for Field-Usable Monitoring Tools
    • Rising Emphasis on Zero-Waste and Last-Mile Integrity Supports Innovation in Multi-Stage or Multi-Threshold VVMs
    • Emerging Interest in Time-Temperature Indicators (TTIs) for Biologics Fuels Broader Application of VVM Technology
    • Global Push for Vaccine Equity and Reliability Encourages Localization and Technology Transfer of VVM Production
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vaccine Vial Monitors Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vaccine Vial Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Multi-Dose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Multi-Dose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Multi-Dose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Single Dose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Single Dose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Single Dose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Preventive Vaccine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Preventive Vaccine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Preventive Vaccine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Therapeutic Vaccine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Therapeutic Vaccine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Therapeutic Vaccine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • CHINA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: China 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Vaccine Vial Monitors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: France 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Vaccine Vial Monitors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • INDIA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: India 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Vaccine Vial Monitors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Vaccine Vial Monitors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030

IV. COMPETITION